191 related articles for article (PubMed ID: 15288318)
1. In vitro antagonism between beta-lactam and macrolide in Streptococcus pneumoniae: how important is the antibiotic order?
Ortega M; Marco F; Soriano A; Gómez J; Almela M; Mensa J
Int J Antimicrob Agents; 2004 Aug; 24(2):178-80. PubMed ID: 15288318
[TBL] [Abstract][Full Text] [Related]
2. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
Gosbell IB; Fernandes LA; Fernandes CJ
Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
[TBL] [Abstract][Full Text] [Related]
3. In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains.
Rodríguez-Cerrato V; García P; Del Prado G; García E; Gracia M; Huelves L; Ponte C; López R; Soriano F
J Antimicrob Chemother; 2007 Nov; 60(5):1159-62. PubMed ID: 17827138
[TBL] [Abstract][Full Text] [Related]
4. Proinflammatory activation of Toll-like receptor-2 during exposure of penicillin-resistant Streptococcus pneumoniae to beta-lactam antibiotics.
Moore LJ; Gilbey AM; Dowson CG; Pridmore AC; Dower SK; Read RC
J Antimicrob Chemother; 2007 Jan; 59(1):35-42. PubMed ID: 17079241
[TBL] [Abstract][Full Text] [Related]
5. Lack of synergy of erythromycin combined with penicillin or cefotaxime against Streptococcus pneumoniae in vitro.
Lin E; Stanek RJ; Mufson MA
Antimicrob Agents Chemother; 2003 Mar; 47(3):1151-3. PubMed ID: 12604560
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of synergy of combinations of beta-lactams with fluoroquinolones or a macrolide in Streptococcus pneumoniae.
Drago L; Nicola L; Rodighiero V; Larosa M; Mattina R; De Vecchi E
J Antimicrob Chemother; 2011 Apr; 66(4):845-9. PubMed ID: 21393187
[TBL] [Abstract][Full Text] [Related]
7. [Antibiotic sensitivity of Streptococcus pneumoniae in Tunisia: results of a multicenter study (1998-1999)].
Mahjoubi-Rhimi F; Kechrid A; Boutiba I; Mezghani S; Kamoun A; Smaoui H; Thabet L; Ben Redjeb S; Hammami A
Tunis Med; 2003 Mar; 81(3):167-71. PubMed ID: 12793066
[TBL] [Abstract][Full Text] [Related]
8. Use of penicillin MICs to predict in vitro activity of other beta-lactam antimicrobial agents against Streptococcus pneumoniae.
Brueggemann AB; Pfaller MA; Doern GV
J Clin Microbiol; 2001 Jan; 39(1):367-9. PubMed ID: 11136803
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic activity of ertapenem versus penicillin-susceptible and penicillin-non-susceptible Streptococcus pneumoniae using an in vitro model.
Zhanel GG; Derkatch S; Laing N; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2007 Jan; 59(1):144-7. PubMed ID: 17079238
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of beta-lactams against experimental pneumococcal endocarditis caused by strains with different susceptibilities to penicillin.
Pichardo C; Docobo-Pérez F; Pachón-Ibáñez ME; Jiménez-Mejías ME; García-Curiel A; Caballero-Granado FJ; Moreno-Maqueda I; Pachón J
J Antimicrob Chemother; 2005 Oct; 56(4):732-7. PubMed ID: 16150863
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibilities and distribution of resistance genes for beta-lactams and macrolides in Streptococcus pneumoniae isolated between 2002 and 2004 in Tokyo.
Noguchi N; Tano J; Nasu Y; Koyama M; Narui K; Kamishima H; Saito T; Tsuyuki K; Sasatsu M
Int J Antimicrob Agents; 2007 Jan; 29(1):26-33. PubMed ID: 17189091
[TBL] [Abstract][Full Text] [Related]
12. Antagonism between penicillin and erythromycin against Streptococcus pneumoniae in vitro and in vivo.
Johansen HK; Jensen TG; Dessau RB; Lundgren B; Frimodt-Moller N
J Antimicrob Chemother; 2000 Dec; 46(6):973-80. PubMed ID: 11102417
[TBL] [Abstract][Full Text] [Related]
13. Beta-lactam activity against penicillin-resistant Streptococcus pneumoniae strains exhibiting higher amoxicillin versus penicillin minimum inhibitory concentration values: an in vitro pharmacodynamic simulation.
Sevillano D; Aguilar L; Alou L; Giménez MJ; González N; Echeverría O; Torrico M; Valdes L; Coronel P; Prieto J
Chemotherapy; 2008; 54(2):84-90. PubMed ID: 18303256
[TBL] [Abstract][Full Text] [Related]
14. [Sensitivity to beta lactams and macrolides of Streptococcus pyogenes isolated at the services from 1994 to 1998].
Nait-Kaci S; Boukarana W; Rahal K
Arch Inst Pasteur Alger; 1998; 62():13-23. PubMed ID: 11256303
[TBL] [Abstract][Full Text] [Related]
15. Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997).
Granizo JJ; Aguilar L; Casal J; García-Rey C; Dal-Ré R; Baquero F
J Antimicrob Chemother; 2000 Nov; 46(5):767-73. PubMed ID: 11062196
[TBL] [Abstract][Full Text] [Related]
16. Macrolide and azithromycin use are linked to increased macrolide resistance in Streptococcus pneumoniae.
Bergman M; Huikko S; Huovinen P; Paakkari P; Seppälä H;
Antimicrob Agents Chemother; 2006 Nov; 50(11):3646-50. PubMed ID: 16940064
[TBL] [Abstract][Full Text] [Related]
17. Population antibiotic susceptibility for Streptococcus pneumoniae and treatment outcomes in common respiratory tract infections.
Furuno JP; Metlay JP; Harnett JP; Wilson J; Langenberg P; McGregor JC; Zhu J; Perencevich EN
Pharmacoepidemiol Drug Saf; 2006 Jan; 15(1):1-9. PubMed ID: 16136615
[TBL] [Abstract][Full Text] [Related]
18. MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -resistant pneumococci.
Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1996 Sep; 40(9):2071-4. PubMed ID: 8878583
[TBL] [Abstract][Full Text] [Related]
19. Predicting Oral Beta-lactam susceptibilities against Streptococcus pneumoniae.
Murphy ME; Powell E; Courter J; Mortensen JE
BMC Infect Dis; 2021 Jul; 21(1):679. PubMed ID: 34256734
[TBL] [Abstract][Full Text] [Related]
20. Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness.
Soriano F; Cafini F; Aguilar L; Tarragó D; Alou L; Giménez MJ; Gracia M; Ponte MC; Leu D; Pana M; Letowska I; Fenoll A
J Antimicrob Chemother; 2008 Dec; 62(6):1234-40. PubMed ID: 18799472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
